TIM-3 positive cells showed functional defects like decreased cytotoxicity and reduced production of IFN-γ and granzyme B. TIM-3 expression also correlated with lymph node metastasis, clinical stage, and tumor invasion (136). The gene discussed is HAVCR2; the disease is metastatic malignant neoplasm in the lymph nodes.